Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN NEPHROLOGY

January 2021

NEPHROLOGY

QUAGGIN SELECTED TO LEAD AMERICAN SOCIETY OF NEPHROLOGY

Featuring: ​​Susan Quaggin, MD,
​
​​Susan Quaggin, MD, the Charles H. Mayo, MD, Professor and chief of Nephrology and Hypertension in the Department of Medicine, has been elected president of the American Society of Nephrology (ASN).

“It is an honor and a privilege to lead such an incredible organization,” said Quaggin, who is also director of the Feinberg Cardiovascular and Renal Research Institute (FCVRI). “ASN staff, councilors and members are all working towards one goal — a world without kidney diseases — and their dedication, commitment and tireless work to advocate for patients with kidney diseases is incredible.”

Quaggin takes the reins at ASN at a time where kidney care is undergoing a dramatic transformation: new classes of drugs that better protect the kidneys in patients with diabetes or chronic kidney disease, greater attention on disparities and technologic advances that put bio-engineered kidneys just over the horizon.

During her term, Quaggin said she expects to focus on reducing disparities in kidney care and education through programs such as loan mitigation for trainees who are underrepresented in medicine and initiatives to ensure access to new therapies for as many patients as possible.

“It is tremendously exciting to see these talented and committed professionals apply so many new tools to advance care and cure kidney diseases, and I look forward to leading ASN as it advances innovation and care,” Quaggin said.

Quaggin first joined Northwestern in 2013 and has worked to close the gap between scientific discovery and patient care for kidney and cardiovascular diseases. Her science has enhanced the understanding of common glomerular diseases and inspired the development of promising therapeutics, including discoveries regarding blood vessels, lymphatics and specialized hybrid circulations.

Quaggin was elected to the American Society for Clinical Investigation in 2006, the Association of American Physicians in 2013, and the National Academy of Medicine in 2019.
​
“I am forever grateful to the patients with kidney diseases whose stories inspire me every day and gave me my purpose in life,” Quaggin said. “They set me on my path to become a nephrologist and a physician-scientist with one goal: to end kidney diseases.”
The ASN, founded in 1966, has more than 20,000 members from 131 countries. The society represents health professionals and scientists in the fight to prevent, treat and cure kidney diseases.

This article was originally published in the Feinberg School of Medicine News Center on January 21, 2021. 
Doctor Susan Quaggin headshot
Dr. Susan Quaggin, MD, FRCP(C), FASN is a physician-scientist and nephrologist in Chicago, Illinois. She is currently licensed to practice medicine in Illinois and Ontario, Canada. She is the Chief of the Division of Nephrology and Hypertension at Northwestern Medicine and the Director of the Cardiovascular and Renal Research Institute. Her work bridges clinical and basic discovery with a goal to develop and implement new treatments for patients with kidney and vascular diseases. Areas of focus include glomerular diseases, thrombotic microangiopathy and diabetic kidney disease. ​

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM nephrologist

You May Also Like

video still of Vikram Aggarwal, MD

September 2020

NEPHROLOGY
Home Hemodialysis Program at Northwestern Medicine
Video still of Pinelopi Kapitsinou, MD

December 2020

NEPHROLOGY
Exploring Molecular Mechanisms of Kidney Disease
John Friedewald​headshot and Aneesha Shetty, MD headshot

February 2020

NEPHROLOGY
Examining the Long-Term Health of Living Kidney Donors

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2026 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties